Introduction {#s1}
============

Objective assessment of respiratory function is crucial for the diagnosis and monitoring of patients with asthma \[[@C1]\]. Whereas spirometry remains the gold standard, oscillometry (or forced oscillation technique) is one of several techniques to measure lung function that has been shown to be discriminative and responsive to change \[[@C2]--[@C5]\]. Importantly, oscillometry is an effort-independent technique requiring minimal cooperation, which makes it very attractive in children, particularly in pre-schoolers and those too sick to cooperate with spirometry \[[@C6]\]. The MasterScreen (CareFusion, Hochberg, Germany) uses an impulse oscillometry system (IOS) producing a square wave (more accurately, a Dirac function) to generate oscillations. Several recently commercialised instruments, such as the tremoFlo C-100 (Thorasys, Montreal, QC, Canada), MostGraph (CHEST M.I., Tokyo, Japan) and Resmon Pro (Medical Graphics Diagnostics, Rome, Italy), generate multifrequency oscillations using gentle sinusoidal airwaves superimposed on the patient\'s respiratory airflow. The use of different oscillation technologies, transducers and analytic algorithms raises the question as to whether the agreement between values obtained on different oscillometry instruments is sufficient to use the same normative and interpretative cut-off values, interchangeably.

Commercially available since 1992, most published reference values have been developed on the IOS in Caucasian \[[@C7]--[@C10]\] and non-Caucasian children \[[@C11]--[@C13]\]; to the best our knowledge, only one has been published on the tremoFlo, in Emirati children \[[@C14]\]. Yet, using fixed phantom models, the MasterScreen IOS and MostGraph did not generate identical impedance values, with up to 10% variation from the test charges (*i.e.* a resistor with known resistance), resulting in differences in resistance and reactance \[[@C15]\]. Whereas similar resistance values were observed in healthy adults between the tremoFlo, Resmon Pro and a custom-built device ("WIMR"), \>10% variation was observed when compared with the IOS \[[@C16]\]. The tremoFlo offers a monofrequency mode at 7 Hz, which may be preferred to 5 Hz to improve the signal/noise ratio in children with a higher respiratory rate \[[@C17]\]. Clinical interpretation of values at 7 Hz is hampered by the absence of paediatric reference values at this frequency; perhaps using 5 Hz reference values with a correction factor could address the issue. To the best of our knowledge, no between-device comparison of parameters measured at 5 *versus* 7 Hz has been published in children.

The objectives of this study were to examine, in asthmatic children, the agreement between 1) various respiratory impedance parameters at 5--25 Hz on the MasterScreen IOS and the tremoFlo C-100, and 2) total- and within-breath parameters measured at 5 *versus* 7 Hz on the tremoFlo.

Methods {#s2}
=======

We conducted a prospective cross-sectional study, with three sets of oscillometry measurements, in children presenting to the Asthma Clinic of the Sainte-Justine University Hospital Centre (Montreal, QC, Canada), a tertiary care academic centre. The study was approved by the Institutional Review Board. Parents provided written informed consent and assent was obtained in children aged ≥8 years.

Children were eligible if they fulfilled the following conditions: 1) aged 3--17 years, 2) suspected or confirmed asthma, 3) no intake of short-acting bronchodilators in the 4 h preceding measurements, 4) no spirometry testing in the 30 min preceding measurements, 5) ability to collaborate with oscillometry, and 6) prior consent to participate in our Paediatric Asthma Database and Biobank. Children were excluded if they were not able to breathe through a mouthpiece without a leak or if enrolled in another study.

We documented basic demographics including age, sex, ethnicity, height and weight. Asthma control was ascertained using the validated Childhood Asthma Control Test (cACT) \[[@C18]\] for children aged 4--11 years and the Asthma Control Test (ACT) \[[@C19]\] for children aged ≥12 years; a value \<20 on either test was indicative of poor asthma control. Measurements of respiratory impedance were obtained in random order at the 5--10--15--20--25 Hz multifrequency mode (hereafter referred to as 5--25 Hz) on the MasterScreen IOS and the tremoFlo C-100 using the harmonic soft impulse signal, and at the 7 Hz monofrequency on the tremoFlo. The order of the three test modes was determined by a simple randomisation procedure with a fixed block size of 6; allocation concealment was achieved by consecutively numbered opaque envelopes containing the test order. Oscillometry measurements were obtained using a previously described standardised technique \[[@C2]\]. Briefly, children breathed quietly through the mouthpiece wearing a nose clip, with the chin and neck positioned at 90°, and with the technician, parents or patient holding the child\'s cheeks to minimise the upper airway shunt. At least four consecutive breathing cycles, without any evidence of swallowing, obstruction of the mouthpiece with the tongue or other artefacts, were selected by the operator on the IOS, whereas a similar selection was made automatically, without the operator\'s influence, on the 16 s tremoFlo measurement. Two different operators, blinded to the results on the alternate oscillometry instrument, administered the tests on the tremoFlo and IOS, to ensure that the results of the tremoFlo did not influence the selection of breaths on the IOS. Up to six trials were performed for each measurement to obtain at least three resistance values at 5 Hz (*R*~5~) or 7 Hz (*R*~7~) with a coefficient of variation of ≤15%, as criteria for reproducibility \[[@C2]\]. The average value of three reproducible measurements was reported for each parameter. The devices were calibrated daily according to the manual of procedures established from the user manuals.

Statistics {#s2a}
----------

Assuming a high agreement, a sample of 45 patients was sufficient to identify an intraclass correlation coefficient (ICC) of 0.925 with a precision of ±0.075, resulting in a 95% confidence interval encompassing 0.85--1.00 absolute agreement. Anticipating 10% withdrawals due to insufficient reproducibility, we sought *a priori* to recruit 50 patients.

Categorical variables were reported as count (percentage), and continuous variables as mean with standard deviation and median with interquartile range. The absolute agreement between the within-patient average resistance (*R*) and reactance (*X*) values at each frequency (5--25 Hz) as well as the frequency dependence (*R*~5--20~ and *X*~5--20~) on both devices was examined using the ICC: values \>0.90 were indicative of excellent agreement, whereas values between 0.75--0.90 and 0.50--0.75 portrayed good and moderate agreement, respectively \[[@C20]\]. The possibility of two types of systematic bias was examined: a fixed bias was explored by the absolute within-patient difference in kPa·L^−1^·s^−1^ (paired t-test after confirming the normality of the distribution) and reported with 95% confidence intervals, whereas a proportional bias, *i.e.* an increasing (or decreasing) systematic deviation with increasing impedance, was examined by a linear regression model. Bland--Altman plots served to determine agreement and bias \[[@C21]\]. The same approaches were used to compare within-breath parameters obtained at 5 *versus* 7 Hz on the tremoFlo. Statistical tests were considered significant when p≤0.05. No adjustment was made for multiple testing in this exploratory study. The data were analysed using SAS version 9.3 (SAS Institute, Cary, NC, USA) and SPSS Statistics for Windows version 24.0 (IBM, Armonk, NY, USA).

Results {#s3}
=======

Between January and May 2017, 137 patients were approached; 47 children were ineligible. Of the 90 eligible children, 50 (56%) participants were randomised. Six patients did not complete all three testing modes. 46 patients completed testing at 5--25 Hz on both devices, with reproducible results documented in 38 (83%) patients who contributed data to the tremoFlo--IOS agreement analysis. 44 children completed reproducible measurements at 5--25 and 7 Hz on the tremoFlo, contributing data to the 5 *versus* 7 Hz agreement analysis ([figure 1](#F1){ref-type="fig"}).

![Patient selection from screening to analysis. IOS: MasterScreen impulse oscillometry system. ^\#^: in seven patients, the coefficient of variation of repeated measures exceeded 15%, whereas in one patient, the mean of three values was recorded, but the individual values were lost, preventing confirmation of the coefficient of variation.](00138-2018.01){#F1}

Among the 46 patients contributing data to any comparison, the mean±[sd]{.smallcaps} age of participants was 8.5±3.7 years with 39% aged 3--6 years and there was a balanced sex distribution; 25% had poor clinical control and the mean±[sd]{.smallcaps} *R*~5~ was 0.5±1.06 with 15.8% displaying a *R*~5~ z-score of ≥2 ([table 1](#TB1){ref-type="table"}) \[[@C9]\]. The mean coefficient of variation of *R*~5~ was 8%; the same was observed for impedance at 5--25 Hz ([supplementary table E1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00138-2018.figures-only#fig-data-supplementary-materials)).

###### 

Patient characteristics

  ------------------------------------------ -----------
  **Patients**                                   46
  **Age years**                              
   3--6                                       18 (39.1)
   7--11                                      19 (41.3)
   12--17                                     9 (19.6)
  **Female**                                  24 (52.2)
  **Ethnicity**                              
   Caucasian                                   23 (50)
   Asian                                      7 (15.2)
   Arab                                        4 (8.7)
   Black                                       4 (8.7)
   Latin American                              4 (8.7)
   Interracial                                 4 (8.7)
  **Asthma control (n=44)**                  
   cACT or ACT \<20^\#^                       11 (25.0)
  ***R***~**5**~**^¶^** **z-score (n=38)**   
   \<0                                        13 (34.2)
   0--1                                       14 (36.8)
   1--2                                       5 (13.2)
   ≥2                                         6 (15.8)
  ------------------------------------------ -----------

Data are presented as n or n (%). cACT: Childhood Asthma Control Test; ACT: Asthma Control Test; IOS: impulse oscillometry system. ^\#^: cACT for children aged 4--11 years \[18\], whereas ACT for children aged ≥12 years \[19\]; for both tests, a score of \<20 indicates poor control (the missing values refer to children aged \<4 years); ^¶^: resistance at 5 Hz measured on the MasterScreen impulse oscillometry system (IOS) and reported using IOS-specific normative values for children aged 3--18 years \[9\].

Overall, the mean resistance values were slightly higher and the mean reactance slightly more negative on the tremoFlo than the IOS; the same held true when medians were considered. The ICC between the IOS and tremoFlo values at each oscillatory frequency (5--25 Hz) varied between 0.88 and 0.91 for resistance, and between 0.69 and 0.87 for reactance; it was 0.83 for Δ*R*~5--20~, 0.70 for Δ*X*~5--20~ and 0.63 for resonant frequency ([table 2](#TB2){ref-type="table"}).

###### 

Within-patient absolute agreement between tremoFlo and MasterScreen impulse oscillometry system (IOS) values

                        **Patients n**   **tremoFlo kPa·L^−1^·s^−1^**   **IOS kPa·L^−1^·s^−1^**   **tremoFlo *versus* IOS ICC (95% CI)**                 
  -------------------- ---------------- ------------------------------ ------------------------- ---------------------------------------- -------------- -------------------
  **Resistance^\#^**                                                                                                                                     
   *R*~5~                     38                  0.80±0.35                   0.71 (0.34)                       0.82±0.31                  0.72 (0.34)    0.91 (0.83--0.95)
   *R*~10~                    38                  0.74±0.30                   0.67 (0.28)                       0.66±0.21                  0.60 (0.26)    0.91 (0.82--0.95)
   *R*~15~                    38                  0.63±0.25                   0.57 (0.25)                       0.60±0.17                  0.54 (0.22)    0.90 (0.80--0.95)
   *R*~20~                    38                  0.59±0.22                   0.53 (0.26)                       0.56±0.15                  0.52 (0.19)    0.88 (0.77--0.94)
   *R*~25~                    38                  0.56±0.20                   0.51 (0.24)                       0.55±0.15                  0.51 (0.21)    0.91 (0.82--0.95)
   *R*~5--20~                 38                  0.21±0.18                   0.18 (0.17)                       0.26±0.21                  0.23 (0.19)    0.83 (0.68--0.91)
  **Reactance^\#^**                                                                                                                                      
   *X*~5~                     38                  −0.36±0.20                 −0.31 (0.16)                       −0.19±0.14                 −0.18 (0.14)   0.75 (0.52--0.87)
   *X*~10~                    38                  −0.18±0.17                 −0.13 (0.16)                       −0.16±0.13                 −0.14 (0.15)   0.82 (0.66--0.91)
   *X*~15~                    38                  −0.17±0.16                 −0.12 (0.12)                       −0.10±0.11                 −0.09 (0.14)   0.87 (0.76--0.93)
   *X*~20~                    38                  −0.09±0.14                 −0.06 (0.11)                       −0.02±0.08                 −0.01 (0.09)   0.78 (0.58--0.89)
   *X*~25~                    38                 0.002±0.123                  0.02 (0.12)                       0.06±0.06                  0.05 (0.09)    0.69 (0.40--0.84)
   *X*~5--20~                 38                  −0.27±0.09                 −0.25 (0.09)                       −0.17±0.13                 −0.19 (0.17)   0.70 (0.42--0.84)
   *AX*^¶^                    38                  3.25±2.92                   2.40 (2.31)                                                                
   *F*~res~^+^                26                  19.64±4.59                 21.67 (6.01)                       18.46±3.65                 19.25 (3.86)   0.63 (0.38--0.82)

IQR: interquartile range; ICC: intraclass correlation coefficient; *AX*: area under the curve for resistance; *F*~res~: resonant frequency. ^\#^: *R* represents resistance and *X* represents reactance at various oscillatory frequencies, including the frequency dependency between *R* or *X* parameters measured at 5--20 Hz; ^¶^: only available on the tremoFlo, such that no agreement was examined with the IOS; ^+^: reported only for patients in whom it was ≤25 Hz, to avoid extrapolation of data.

As for fixed biases, there was no statistically significant absolute mean difference in resistance at most frequencies, with the exception of 10 Hz (p=0.003) and *R*~5--20~ (p=0.04) where the absolute difference reached ≥0.05 kPa·L^−1^·s^−1^. However, the opposite was observed in reactance, where the absolute differences were statistically significant and exceeded 0.05 kPa·L^−1^·s^−1^ at all frequencies, except 10 Hz. A statistically significant proportional difference was observed for all resistance and reactance parameters (except *R*~5~) where the tremoFlo and IOS values differed by a multiplicative factor varying between 0.30--0.42 and 0.35--0.79 for every kPa·L^−1^·s^−1^ unit of resistance and reactance, respectively. A *post hoc* sensitivity analysis excluding an outlier present only at *R*~5~ showed no evidence of a fixed bias (mean difference 0.00, 95% CI −0.05--0.06; p=0.95), but suggested a significant proportional bias (β 0.27, 95% CI 0.11--0.44; p=0.002). As graphically displayed in the Bland--Altman plots, resistance values were proportionally higher and reactance values more negative on the tremoFlo compared with the IOS, with increasing impedance ([figure 2](#F2){ref-type="fig"}). The potential impact of the observed proportional difference on clinical interpretation was examined using the same IOS-specific normative values for both devices \[[@C9]\]. For any resistance of 0.75--1.5 kPa·L^−1^·s^−1^ on the IOS, the projected *R*~10~ values measured on the tremoFlo resulted in a z-score difference varying between 0.4 and 1.7 for both a typical 4.0-year-old (105 cm) male and a typical 8.5-year-old (129 cm) male, with higher z-score attributed to the tremoFlo values ([table 3](#TB3){ref-type="table"}).

###### 

a--l) Bland--Altman plots of absolute differences between tremoFlo and MasterScreen impulse oscillometry system (IOS) measurements *versus* the mean of the two measurements in resistance *R* (left panels) at a) 5, c) 10, e) 15, g) 20, i) 25 and k) 5--20 Hz and in reactance *X* (right panels) at b) 5, d) 10, f) 15, h) 20, j) 25 and l) 5--20 Hz in 38 patients with reproducible IOS measurements. MD: mean difference. In each plot, the black solid horizontal line represents the absolute within-patient MD between parameters measured on the tremoFlo minus those on the IOS, with 95% of all absolute differences contained within the black dashed horizontal lines. These values are indicated as MD (95% CI) in kPa·L^−1^·s^−1^ at the top of each plot: values \>0 indicate that tremoFlo measurements were higher than IOS measurements and *vice versa*. The magnitude and direction of the proportional bias is depicted by the green linear regression line with the 95% confidence interval and is indicated as β (95% CI) at the bottom of each plot.

![](00138-2018.02a)
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###### 

Projected impact of observed proportional bias on interpretation

  **Resistance**     **Measurements**   **4-year-old male (105** **cm)**   **8.5-year-old male (129** **cm)**                                 
  ----------------- ------------------ ---------------------------------- ------------------------------------ ------- ------- ------ ------- -------
  ***R***~**5**~           0.75                       0.73                               −1.35                  −1.44   0.09    0.20   0.10    0.09
  1                        1.01                      −0.27                               −0.22                  −0.05   1.28    1.33   −0.05  
  1.25                     1.29                       0.82                                1.01                  −0.19   2.37    2.56   −0.19  
  1.5                      1.58                       1.90                                2.24                  −0.33   3.45    3.79   −0.33  
  ***R***~**10**~          0.75                       0.85                               −0.71                  −0.28   −0.43   0.68   1.11    −0.43
  1                        1.19                       0.39                                1.24                  −0.85   1.79    2.64   −0.85  
  1.25                     1.54                       1.50                                2.77                  −1.27   2.90    4.17   −1.27  
  1.5                      1.88                       2.61                                4.30                  −1.69   4.00    5.69   −1.69  

IOS: MasterScreen impulse oscillometry system. ^\#^: based on the observed average resistance- and oscillatory frequency-specific proportional bias (note: we conservatively used the bias observed in 38 children, without removing the outlier identified for *R*~5~); ^¶^: z-score values calculated using IOS-specific paediatric normative values \[9\]; ^+^: z-score difference between those derived from the IOS *versus* tremoFlo, with negative values indicating a lower z-score value on the IOS than the tremoFlo.

The ICC between whole-breath, average inspiratory and expiratory parameters measured at 5 Hz on the 5--25 Hz multifrequency mode and 7 Hz monofrequency on the tremoFlo was ≥0.97 for resistance and ≥0.94 for both reactance and the within-breath difference of resistance (Δ*R*); it fell to 0.79 in within-breath reactance (Δ*X*). The absolute mean difference was statistically significant for inspiratory resistance (p=0.008) and for all reactance parameters including Δ*X*, where it was ≥0.04 kPa·L^−1^·s^−1^ ([supplementary table E2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00138-2018.figures-only#fig-data-supplementary-materials)). There was a statistically significant proportional difference for resistance and reactance in all parameters, except inspiratory reactance; larger resistance and more negative reactance values were observed at 5 than 7 Hz ([figure 3](#F3){ref-type="fig"}).

![a--d) Bland--Altman plots of absolute differences between tremoFlo at 5 and 7 Hz *versus* the mean of the two measurements in resistance *R* and reactance *X* in 44 patients with reproducible measurements for a) *R* and b) *X* and in 42 patients for c) Δ*R* and d) Δ*X*. MD: mean difference. In each plot, the black solid horizontal line represents the absolute MD, with 95% of all absolute differences contained within the black dashed horizontal lines. These values are indicated as MD (95% CI) in kPa·L^−1^·s^−1^ at the top of each plot: values \>0 indicate that tremoFlo measurements at 5 Hz are higher than at 7 Hz and *vice versa*. The magnitude and direction of the proportional bias is depicted by the green linear regression line with the 95% confidence interval and is indicated as β (95% CI) at the bottom of each plot.](00138-2018.03){#F3}

Discussion {#s4}
==========

In our cohort of asthmatic children, the within-patient absolute agreement (ICC) between the IOS and tremoFlo was excellent for resistance values and moderate-to-good for reactance. However, resistance measurements on the tremoFlo were consistently higher, reactance values more negative and resonance frequency higher than measured on the IOS. While the average within-patient absolute differences were generally clinically small (\<0.10 kPa·L^−1^·s^−1^), a proportional bias was observed in resistance at 10--25 Hz and in reactance at all oscillation frequencies; this bias is likely to erroneously affect the clinical interpretation of respiratory resistance and reactance if measurements obtained on the tremoFlo are interpreted using IOS-specific normative values; this applies particularly to patients with higher resistance. The findings suggest the need for better standardisation of measurements across oscillometry devices. Until then, it seems prudent to use instrument-specific normative values for interpretation.

The commercialisation of new oscillometry devices raises the question as to whether normative values elaborated on another device, using a different waveform, data algorithm and/or oscillation frequency, can be used interchangeably. The literature on the topic is scarce with only three publications; all identified measurement discrepancies, both *in vitro* and/or *in vivo*, between oscillometry devices \[[@C15], [@C16], [@C22]\]. We observed lower resistance values at ≥10 Hz, higher frequency dependence of resistance (Δ*R*~5--20~) and less negative reactance on the IOS than the tremoFlo. These findings are consistent with the 10% difference observed by T[animura]{.smallcaps} *et al.* \[[@C15]\] comparing the IOS to the MostGraph using test charges of 0.196, 0.402 and 0.951 kPa·L^−1^·s^−1^ under different respiratory rates and tidal volumes. Z[immermann]{.smallcaps} *et al.* \[[@C16]\] compared the tremoFlo, Resmon Pro, IOS and a custom-built device ("WIMR") in 12 healthy adults as well as against a fixed resistance of 0.20 kPa·L^−1^·s^−1^ and reactance of −0.31 kPa·L^−1^·s^−1^. Although no significant differences were observed between the test charges and devices, the *in vivo* resistance on the IOS differed significantly from that of the other two devices, with higher resistance and more negative reactance in the former. The direction of these differences contradicted our findings and is probably explained in part by the higher resistance displayed by our asthmatic children, with a mean *R*~5~ of 0.80 kPa·L^−1^·s^−1^ compared with \<0.3 kPa·L^−1^·s^−1^ in healthy adults, and the test charges used; moreover, our larger spectrum of resistance from 0.30 to 1.78 kPa·L^−1^·s^−1^ on the IOS enabled the identification of a proportional bias, which was probably not detectable in healthy adults or with a low test charge. To date, other comparisons of IOS with other non-IOS instruments using test charges or subjects have only been published in abstract form \[[@C23]--[@C25]\]; they consistently reported significant between-device variation exceeding within-patient variability, particularly with parameters other than *R*~5~, supporting between-device impedance differences.

Our observed between-device overall difference in resistance was negligible at 5 Hz, one of the most commonly used frequencies. However, the *post hoc* exclusion of an outlier revealed a similar proportional bias to that observed with all other oscillatory frequencies; this observation deserves further confirmation. With increasing interest in reactance and in the frequency dependence of resistance as more sensitive markers of small airway obstruction than resistance at 5 Hz, the observed between-device difference may be problematic. Importantly, the observed proportional bias in resistance at ≥10 Hz (and 5 Hz, after removing an outlier) and in reactance at all oscillation frequencies increased by ∼30% for every 1 kPa·L^−1^·s^−1^. In our case simulations, the distortion between the values obtained on IOS *versus* tremoFlo was most clinically important above 1 kPa·L^−1^·s^−1^ for *R*~10~, where a z-score difference in the interpretation exceeded 0.80. This suggests that the between-device difference may cause significant distortion in the interpretation of findings.

As expected, resistance values were marginally lower, but reactance values were significantly less negative at 7 than 5 Hz for all intrabreath reactance parameters (inspiratory, expiratory and Δ*X*). Yet, the statistically significant proportional bias indicates that the interpretation of resistance or reactance at 7 Hz using 5 Hz normative values would underestimate the severity of obstruction, particularly in small children and more obstructed individuals. Frequency-specific reference values are thus required.

The study must be interpreted in light of the following strengths and limitations. Acknowledging various sources of biases to explain measurement discrepancies, including differences in the population, setting, measurement procedures, within-patient variation and device specifications, our design aimed to minimise the former four biases. We performed within-patient comparison of measurements obtained in the same setting, using the same procedures, with two operators blinded to measurements obtained on the alternate device, allocation concealment until randomisation and random testing order; the latter served to avoid systematic differences due to patient fatigue with repeated measurements. While we cannot exclude the possibility of within-patient between-measurement variation, such variation is reported to be small \[[@C17], [@C26]\], and would be random and thus minimised by the randomised measurement order. Observed between-device measurement differences are therefore more likely to be due to differences in device specifications, including transducers and data processing algorithms. Perhaps a higher within-patient variation in diseased than in healthy individuals could have contributed to the observed between-device variation \[[@C27]\]; however, the observations were made in asthmatic children, a group in whom oscillatory resistance is frequently used. We recognised the possibility of a lower accuracy in measuring *R*~5~ from a 5--25 Hz signal than *R*~7~ with a monofrequency oscillation. The adequate study power and consistency of findings across various agreement parameters underline the robustness of the findings. In the absence of correction for multiple testing, we cannot rule out the possibility of false-positive findings. As we enrolled asthmatic children with a large spectrum of impedance, a sizeable proportion of participants had elevated resistance, enabling the identification of a proportional bias of ≥30%. Yet, given the small absolute number of children with elevated resistance (z-score ≥2 in six children), replication of our findings is needed. In the absence of explicit guideline recommendations regarding the best way to assess reproducibility \[[@C28]\], we excluded children with a coefficient of variation \>15% of resistance at 5 Hz (or 7 Hz), resulting in a mean coefficient of variation of 8%; perhaps longer measurements would have led to lower within-patient variability and fewer exclusions \[[@C29]\]. In the absence of a true gold standard, this comparative study was not designed to identify the oscillometry device providing the most accurate measurements, only to explore agreement and systematic differences. As for generalisation, as participants were predominantly asthmatic children, caution is advised before extrapolating results to adults and healthy children.

Although oscillometry may be more accessible and sensitive to detect small airway obstruction than spirometry \[[@C30], [@C31]\], the observed between-device impedance measurement differences represent an important obstacle to its widespread use. Whereas general recommendations have been issued regarding device specifications \[[@C2], [@C28]\], reference values for oscillometry still vary significantly, interfering with the pooling of normative data \[[@C9], [@C14], [@C32]\]. Clearly, it is imperative to understand and address between-device measurement discrepancies, including the observed fixed and proportional biases, across commercially available devices to facilitate standardisation of oscillometry measurements.

In conclusion, the excellent agreement, small absolute difference and apparent absence of systematic bias in resistance values measured at 5 Hz suggest that *R*~5~ normative values developed on the IOS may perhaps be used for the tremoFlo (although caution is advised due to the impact of outlier removal). However, reference values at 5 Hz cannot be applied to 7 Hz measurements. Due to the large proportional bias observed, the use of tremoFlo-specific normative values is preferred for resistance at ≥10 Hz, frequency dependence and all reactance parameters, to avoid significant discordance in the interpretation of airflow obstruction, particularly in patients with expected higher resistance, such as young children and in those with airflow obstruction.
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